Citation Impact
Citing Papers
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues
1997
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Growth hormone-releasing peptide and its analogues
1995
Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study
2001
Anatomy and regulation of the central melanocortin system
2005 Standout
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
2002
Intranasal Salcatonin (Salmon Calcitonin)
1996
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (F e NO ) for Clinical Applications
2011 Standout
Ghrelin?a hormone with multiple functions
2004
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast
2006
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
1999
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
Effect of Obesity and Feeding on the Growth Hormone (GH) Response to the GH Secretagogue L-692,429 in Young Men1
1997
Osteoporosis: now and the future
2011 Standout
The effect of an opiate antagonist on the hormonal changes induced by hexarelin
1995
Asthma
2017 Standout
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
2003
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Chicken ghrelin and growth hormone-releasing peptide-2 inhibit food intake of neonatal chicks
2002
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Esophagitis Associated with the Use of Alendronate
1996
Ghrelin induces adiposity in rodents
2000 StandoutNature
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
2003
The growth hormone secretagogue receptor
1999
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Asthma
2001 Standout
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
A role for ghrelin in the central regulation of feeding
2001 StandoutNature
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial
2001
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index
2004 Standout
Ghrelin: Structure and Function
2005 Standout
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
2000
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
1997
Zafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
2000
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
In vitro characterization of four novel classes of growth hormone-releasing peptide.
1995
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite
2004 Standout
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
2003
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans
2001 Standout
Prevention of Nonvertebral Fractures by Alendronate
1997
Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents
2002
Interventions for enhancing medication adherence
2008 Standout
Oral Montelukast Versus Inhaled Beclomethasone in 6- to 11-year-old Children with Asthma: Results of an Open-label Extension Study Evaluating Long-term Safety, Satisfaction, and Adherence with Therapy
2001
Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation
2010
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Two-Year Results of Once-Weekly Administration of Alendronate 70 mg for the Treatment of Postmenopausal Osteoporosis
2002
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Interventions for enhancing medication adherence
2014 Standout
Treatment of established osteoporosis: a systematic review and cost-utility analysis
2002
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
A prostaglandin D2receptor antagonist modifies experimental asthma in sheep
2009
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
1995
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children
2003
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
2004
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
2005
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
1999 StandoutNature
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Neuroendocrine Control of Growth Hormone Secretion
1999
Missing outcomes in randomized trials: addressing the dilemma.
2009
Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway
2001
Works of Longsheng Wei being referenced
Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis
1995
Review of guidelines and literature for handling missing data in longitudinal clinical trials with a case study
2006
Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.
1993
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial
1999